Jeffery L. Kutok
NKT Therapeutics (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Protein Degradation and Inhibitors, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning(2002)2,439 cited
- → Regulation of the Germinal Center Response by MicroRNA-155(2007)1,472 cited
- → Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma(2010)1,281 cited
- → PI3Kγ is a molecular switch that controls immune suppression(2016)1,133 cited
- → Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells(2016)849 cited
- → BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma(2005)666 cited